Vivos Therapeutics shares are trading lower. The company announced an offer to sell up to 1.7 million shares of common stock by the selling stockholder.
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics announced an offer to sell up to 1.7 million shares of common stock by the selling stockholder, leading to a decrease in its share price.
April 09, 2024 | 11:51 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Vivos Therapeutics' share price is trading lower following the announcement of a sale offer for up to 1.7 million shares of common stock by the selling stockholder.
The announcement of a significant sale of shares typically leads to a decrease in the stock price due to the potential dilution of existing shares and the increased supply of shares available for purchase. This is a direct impact on Vivos Therapeutics' stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100